Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a colorectal polyp larger than 10mm removed during a colonoscopy using a therapeutic removal technique
- People who have signed a consent form agreeing to take part in the study and to undergo colonoscopy
Who may not be able to join:
- People who have been diagnosed with hereditary conditions linked to colorectal cancer, such as FAP, HNPCC, or similar inherited syndromes
- People for whom a colonoscopy is not considered medically safe or appropriate
- People with severe active inflammatory bowel disease
- People with serious other health conditions, or those considered unlikely to be able to follow the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Stepan Suchanek, assoc. prof., Military University Hospital, Prague
Phone: 973208367
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Development and Clinical Utility of a New Method to Identify Patients With Risk of Recurrent Colorectal Lesions and Personalization of Their Surveillance Based on Mutation Burden and Clinical-pathological Phenotype
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.